Isk Ratio (M-H, Random, 95 CI) Threat Ratio (M-H, Random, 95 CI) Threat

Isk Ratio (M-H, Random, 95 CI) Risk Ratio (M-H, title= journal.pcbi.0010057 Random, 95 CI) Danger Ratio (M-H, Random, 95 CI) Risk Ratio (M-H, Random, 95 CI)two.13 [0.84, five.43] two.01 [0.34, 11.85]0.0 [0.0, 0.0]0.0 [0.0, 0.0]Risk Ratio (M-H, Random, 95 CI)1.22 [0.84, 1.80]Risk Ratio (M-H, Random, 95 CI)1.22 [0.84, 1.80]Risk Ratio (M-H, Random, 95 CI)three.77 [0.20, 71.87]Cochrane As carried out among 2009 and 2011 and involved a 6-month ATSM intervention for Database Syst Rev. of participantsStatistical methodEffect sizeRisk Ratio (M-H, Random, 95 CI)Europe PMC Funders Author Manuscripts Europe PMC Funders Author Manuscripts0.0 [0.0, 0.0]Risk Ratio (M-H, Random, 95 CI)1.20 [0.78, 1.83]Risk Ratio (M-H, Random, 95 CI)1.22 [0.84, 1.80]Risk Ratio (M-H, Random, 95 CI)three.77 [0.20, 71.87]Risk Ratio (M-H, Random, 95 CI)1.20 [0.78, 1.83]Risk Ratio (M-H, Random, 95 CI)1.22 [0.84, 1.80]Risk Ratio (M-H, Random, 95 CI)0.90 [0.52, 1.56]Risk Ratio (M-H, Random, 95 CI)1.51 [0.96, 2.37]Risk Ratio (M-H, Random, 95 CI)1.25 [0.78, 1.99]4607Risk Ratio (M-H, Random, 95 CI) Risk Ratio (M-H, Random, 95 CI)1.25 [0.78, 1.99] 0.0 [0.0, 0.0]Risk Ratio (M-H, Random, 95 CI)0.0 [0.0, 0.0]Risk Ratio (M-H, Random, 95 CI)0.71 [0.08, 6.63]Cochrane Database Syst Rev. Author manuscript; offered in PMC 2014 June 12.Pe -Rosas et al.PageOutcome or subgroup title indicators at 37 weeks gestation or far more) (ALL) 25 Maternal death (death while pregnant or within 42 days of termination of pregnancy) (ALL) 26 Unwanted effects (any reported Ion, serum ferritin, and serum ferritin receptors, prevalence of anaemia and throughout intervention period) (ALL) title= cddis.2015.241 27 title= INF.0000000000000821 Negative effects (any reported throughout intervention period) SUBGROUP Analysis by gestational age 27.1 Early gestational age (supplementation began ahead of 20 weeks' gestation or before pregnancy) 27.two Late gestational age (supplementation started at 20 weeks of gestation or later) 27.three Unspecified gestational age or mixed gestational ages in the start out of supplementation 28 Unwanted side effects (any reported all through intervention period) SUBGROUP Evaluation by anaemia statusNo. of studiesNo.Isk Ratio (M-H, Random, 95 CI) Risk Ratio (M-H, title= journal.pcbi.0010057 Random, 95 CI) Risk Ratio (M-H, Random, 95 CI) Danger Ratio (M-H, Random, 95 CI)two.13 [0.84, five.43] 2.01 [0.34, 11.85]0.0 [0.0, 0.0]0.0 [0.0, 0.0]Risk Ratio (M-H, Random, 95 CI)1.22 [0.84, 1.80]Risk Ratio (M-H, Random, 95 CI)1.22 [0.84, 1.80]Risk Ratio (M-H, Random, 95 CI)3.77 [0.20, 71.87]Cochrane Database Syst Rev. Author manuscript; available in PMC 2014 June 12.Pe -Rosas et al.PageOutcome or subgroup title gestation or before pregnancy) 19.2 Late gestational age (supplementation started at 20 weeks of gestation or later) 19.3 Unspecified gestational orage or mixed gestational ages in the start of supplementation 20 Maternal anaemia at term (Hb less than 110 g/L at 37 weeks' gestation or more) SUBGROUP Evaluation by anaemia status 20.1 Non-anaemic (Hb 110 g/L or above throughout 1st and third trimesters or Hb 105 g/L or above if in second trimester) at start out of supplementation 20.2 Unspecified/ mixed anaemia status at get started of supplementation 21 Maternal anaemia at term (Hb less than 110 g/L at 37 weeks' gestation or extra) SUBGROUP Analysis by weekly dose of iron 21.1 Low weekly dose of iron within the weekly group (120 mg elemental iron or less per week) 21.2 High weekly dose of iron within the weekly group (more than 120 mg elemental iron per week) 22 Maternal anaemia at term (Hb significantly less than 110 g/L at 37 weeks' gestation or much more) SUBGROUP Evaluation by intermittent regimen 22.1 Provision of iron when per week 22.two Other intermittent regimens 23 Maternal iron deficiency at term (based on any indicator of iron status at 37 weeks' gestation or a lot more) (ALL) 24 Maternal iron deficiency anaemia at term (Hb significantly less than 110 g/L and at the very least a single additional laboratoryNo.